[Sevelamer hydrochloride and K/DOQI guidelines].
Yumita
Shigeru
S
D000469:Alkaline Phosphatase / Q000097:blood; D002118:Calcium / Q000097:blood; D002119:Calcium Carbonate / Q000008:administration & dosage; D002762:Cholecalciferol / Q000008:administration & dosage; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D003956:Dialysis / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011073:Polyamines / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D000069603:Sevelamer
D010281:Parathyroid Hormone; D011073:Polyamines; D002762:Cholecalciferol; D010758:Phosphorus; D000069603:Sevelamer; D000469:Alkaline Phosphatase; D002119:Calcium Carbonate; D002118:Calcium